SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2193380

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2193380

North America Flexible Endoscopic Surgery Robot Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3250
PDF & Excel (Multi User License)
USD 4450
PDF & Excel (Enterprise User License)
USD 5750

Add to Cart

The North America Flexible Endoscopic Surgery Robot Market reached USD 657.3 million in 2025 and is projected to grow at an 11.7% CAGR from 2026 to 2035. The market is expected to cross USD 1.98 billion valuation by 2035. Robotic platforms, procedure accessories, navigation software, and service contracts support minimally invasive flexible procedures. Established bronchoscopy programs increasingly generate demand through utilization rather than new system placements alone. Urological use and potential gastrointestinal commercialization broaden the clinical setting, while authorization, reimbursement, and training influence adoption.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$657.3 Million
Forecast Value$1.98 Billion
CAGR11.7%

Broader lung cancer screening eligibility expands the flow of nodules requiring tissue diagnosis. Robotic bronchoscopy serves this diagnostic pathway, supporting recurring accessory and service demand beyond capital-equipment cycles. Outpatient surgical infrastructure creates additional venues where procedural volume, specialist staffing, and reimbursement can support a robotic program. These conditions matter more than facility availability alone. Navigation improvements address another adoption barrier by helping clinicians manage anatomical change and verify targets. AI and integrated imaging can reduce manual steps and make workflows more accessible to community hospitals. Commercial demand therefore combines established respiratory utilization with selective outpatient deployment, where confidence, staffing efficiency, and a viable operating model influence whether hospitals and centers adopt or expand a platform.

Based on category, therapeutic generated USD 425.9 million in 2025. Lesion treatment, stone management, resections, and other interventions broaden the role of flexible robotic equipment beyond navigation and diagnosis. Controlled access and precise instrument use influence its relevance to these procedures. Customers assess whether the platform can support more demanding clinical workflows within their existing care setting. Commercial opportunity depends on suitable indications and the resources required to perform them. The segment reflects a shift toward using robotic assistance within treatment pathways, with procedural capability and clinical integration determining how established platforms can serve additional interventions and contribute to the economics of an installed program.

By application, urology generated USD 217.4 million in 2025. Minimally invasive stone management and other upper-tract procedures provide established pathways for robotic assistance. This clinical base gives providers a route to extend utilization beyond pulmonary programs. Outpatient delivery can support adoption where scheduling and physician expertise align with the required procedure volumes. Commercial demand consequently depends on clinical organization alongside equipment availability. Providers need appropriate staff and a viable workflow to use the platform consistently. The application offers a comparatively established setting for additional robotic activity, linking surgical capability with the practical conditions that determine recurring instrument purchasing and use within hospital or ambulatory programs.

The United States flexible endoscopic surgery robot market is projected to generate USD 1.85 billion by 2035. Early regulatory access, reimbursement pathways, hospital infrastructure, and outpatient facilities support adoption. These conditions connect authorization with training and clinical utilization. Academic centers also provide potential commercial sites for newly cleared gastrointestinal systems. Demand increasingly depends on productivity within the installed base, making navigation improvements and broader indications commercially relevant. Hospital and ambulatory purchasing pathways influence expansion decisions. Suppliers need to support procedural performance and account development, converting early placement into recurring use through instruments and service while addressing the clinical and operational requirements of different facility settings.

Intuitive Surgical held over 58% market share in 2025. Ion's installed base and shape-sensing navigation support its position in robotic bronchoscopy. Accessories and service provide continuing demand as facilities use their platforms. Familiarity among clinicians and institutional customers also influences renewal and expansion decisions. AI and imaging enhancements address expectations for procedural confidence and workflow efficiency. The company's commercial position therefore connects installed relationships with continued platform development. Hospitals assess whether their equipment can keep pace with imaging requirements and clinical workflows. These resources help Intuitive support existing accounts while maintaining the relevance of Ion within programs that increasingly evaluate utilization and recurring procedure support alongside initial capital investment.

Some of the major players in this market are JandJ / Auris Health, Noah Medical, Boston Scientific, Olympus Corporation of the Americas, EndoRobotics, and Medivators (Cantel Medical / Steris). Monarch and Galaxy compete in established bronchoscopy workflows. Boston Scientific brings gastrointestinal tools and physician relationships, while Olympus's distribution arrangement supports ROBOPERA access. Medivators contributes indirectly through reprocessing, maintenance, and infection-control services. Clinical evidence, navigation, training, and operational support distinguish these positions as flexible robotic procedures expand within established and emerging care pathways.

Product Code: 15088

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research Trail & Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by country
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Category trends
    • 2.2.2 Application trends
    • 2.2.3 End use trends
    • 2.2.4 Country trends
  • 2.3 TAM analysis, 2027-2035
  • 2.4 CXO perspectives: strategic imperatives

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factors affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing preference for minimally invasive procedures across North America
      • 3.2.1.2 Advancements in robotic technology & miniaturization
      • 3.2.1.3 Rising prevalence of chronic diseases requiring endoscopic intervention
      • 3.2.1.4 Integration of artificial intelligence (AI) in surgical robotics
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High initial investment & system acquisition costs
      • 3.2.2.2 Limited reimbursement policies for robotic endoscopic procedures
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of single-use robotic endoscopic systems
      • 3.2.3.2 Advancements in AI & machine learning for autonomous surgical navigation
  • 3.3 Growth potential analysis
  • 3.4 Pricing Analysis (Driven by Primary Research)
    • 3.4.1 Historical Price Trend Analysis (Driven by Primary Research)
    • 3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus) (Driven by Primary Research)
  • 3.5 Regulatory landscape
    • 3.5.1 U.S. FDA 510(k), PMA pathways & De Novo classification
    • 3.5.2 Canada - Health Canada medical device classification & MDEL requirements
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Trade Data Analysis (Based on Paid Database)
    • 3.8.1 Import/Export Volume & Value Trends (Based on Paid Database)
    • 3.8.2 Key Trade Corridors & Tariff Impact (Based on Paid Database)
  • 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
    • 3.9.1 AI-Driven Disruption of Existing Business Models
    • 3.9.2 GenAI Use Cases & Adoption Roadmap by Segment
    • 3.9.3 Risks, Limitations & Regulatory Considerations
  • 3.10 Patent / IP Landscape
  • 3.11 Medical Infrastructure Landscape (Driven by Primary Research)
  • 3.12 Epidemiology / Disease Burden

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By Country
      • 4.2.1.1 U.S.
      • 4.2.1.2 Canada
    • 4.2.2 Market Concentration Analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Key developments
    • 4.5.1 Mergers & acquisitions
    • 4.5.2 Partnerships & collaborations
    • 4.5.3 New product launches
    • 4.5.4 Expansion plans and funding
  • 4.6 Company tier benchmarking
    • 4.6.1 Tier classification criteria & qualifying thresholds
    • 4.6.2 Tier positioning matrix by revenue, geography & innovation

Chapter 5. Market Estimates and Forecast, By Category, 2022-2035 ($ Million, Units)

  • 5.1 Key trends
  • 5.2 Therapeutic
  • 5.3 Diagnostic

Chapter 6. Market Estimates and Forecast, By Application, 2022-2035 ($ Million, Units)

  • 6.1 Key trends
  • 6.2 Urology
  • 6.3 Respiratory applications
  • 6.4 Gastrointestinal applications
  • 6.5 Other applications

Chapter 7. Market Estimates and Forecast, By End Use, 2022-2035 ($ Million, Units)

  • 7.1 Key trends
  • 7.2 Hospitals & clinics
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end use

Chapter 8. Market Estimates and Forecast, By Country, 2022-2035 ($ Million, Units)

  • 8.1 Key trends
  • 8.2 U.S.
  • 8.3 Canada

Chapter 9. Company Profiles (Driven by Primary Research)

  • 9.1 Global Players
    • 9.1.1 Intuitive Surgical (Ion)
    • 9.1.2 J&J / Auris Health (Monarch)
  • 9.2 Regional & Emerging Players
    • 9.2.1 Noah Medical (Galaxy)
    • 9.2.2 Boston Scientific
    • 9.2.3 Olympus Corporation of the Americas
    • 9.2.4 Medivators (Cantel Medical / Steris)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!